CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for HitGen Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

HitGen Inc
Block 6,
No.8 Huigu East 1st Road, Tianfu Interna
Phone: +86 2885197385p:+86 2885197385 CHENGDU, SIC  610200  China Ticker: 688222688222
Business Summary
HitGen Inc is a China-based company primarily engaged in the research, development and optimization of small molecule and nucleic acid-based new drug candidates using deoxyribonucleic acid (DNA) encoded chemical library (DEL) technology. Through the drug discovery and optimization platform, the Company provides clients with services such as screening and optimization of designated biological targets, customized DEL design and synthesis, synthesis and modification of certain designated compounds or nucleic acids and related biological evaluation. The Company is also engaged in the transfer of rights and interests in new drug research projects, capital operations and marketing activities. The Company primarily operates its businesses in the domestic market and overseas markets, including the United States, France, the United Kingdom and Japan.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202512/31/2024Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
6794 Patent owners and lessors

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager JinLi 62 6/1/2012 6/1/2012
Vice Chairman of the Board KaiLu 72 2/1/2012 2/1/2012
Finance Director HonggeLiu 55 9/15/2025 4/27/2023
8 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Vernalis Group plc OAKDENE COURT, 613 READING RD, WINNERSH WOKINGHAM United Kingdom

Business Names
Business Name
688222
Vernalis Group plc

General Information
Number of Employees: 483 (As of 12/31/2024)
Outstanding Shares: 400,680,000 (As of 6/30/2025)
Shareholders: 13,716
Stock Exchange: SHA
Fax Number: +86 2883310298


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, October 27, 2025